Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge.

Q2 Medicine
Veerle L Simoens, Sylvie Hébert
{"title":"Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge.","authors":"Veerle L Simoens,&nbsp;Sylvie Hébert","doi":"10.1186/1472-6815-12-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tinnitus is a frequent, debilitating hearing disorder associated with severe emotional and psychological suffering. Although a link between stress and tinnitus has been widely recognized, the empirical evidence is scant. Our aims were to test for dysregulation of the stress-related hypothalamus-pituitary adrenal (HPA) axis in tinnitus and to examine ear sensitivity variations with cortisol manipulation.</p><p><strong>Methods: </strong>Twenty-one tinnitus participants and 21 controls comparable in age, education, and overall health status but without tinnitus underwent basal cortisol assessments on three non-consecutive days and took 0.5 mg of dexamethasone (DEX) at 23:00 on the first day. Cortisol levels were measured hourly the next morning. Detection and discomfort hearing thresholds were measured before and after dexamethasone suppression test.</p><p><strong>Results: </strong>Both groups displayed similar basal cortisol levels, but tinnitus participants showed stronger and longer-lasting cortisol suppression after DEX administration. Suppression was unrelated to hearing loss. Discomfort threshold was lower after cortisol suppression in tinnitus ears.</p><p><strong>Conclusions: </strong>Our findings suggest heightened glucocorticoid sensitivity in tinnitus in terms of an abnormally strong glucocorticoid receptor (GR)-mediated HPA-axis feedback (despite a normal mineralocorticoid receptor (MR)-mediated tone) and lower tolerance for sound loudness with suppressed cortisol levels. Long-term stress exposure and its deleterious effects therefore constitute an important predisposing factor for, or a significant pathological consequence of, this debilitating hearing disorder.</p>","PeriodicalId":39843,"journal":{"name":"BMC Ear, Nose and Throat Disorders","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1472-6815-12-4","citationCount":"37","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Ear, Nose and Throat Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1472-6815-12-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 37

Abstract

Background: Tinnitus is a frequent, debilitating hearing disorder associated with severe emotional and psychological suffering. Although a link between stress and tinnitus has been widely recognized, the empirical evidence is scant. Our aims were to test for dysregulation of the stress-related hypothalamus-pituitary adrenal (HPA) axis in tinnitus and to examine ear sensitivity variations with cortisol manipulation.

Methods: Twenty-one tinnitus participants and 21 controls comparable in age, education, and overall health status but without tinnitus underwent basal cortisol assessments on three non-consecutive days and took 0.5 mg of dexamethasone (DEX) at 23:00 on the first day. Cortisol levels were measured hourly the next morning. Detection and discomfort hearing thresholds were measured before and after dexamethasone suppression test.

Results: Both groups displayed similar basal cortisol levels, but tinnitus participants showed stronger and longer-lasting cortisol suppression after DEX administration. Suppression was unrelated to hearing loss. Discomfort threshold was lower after cortisol suppression in tinnitus ears.

Conclusions: Our findings suggest heightened glucocorticoid sensitivity in tinnitus in terms of an abnormally strong glucocorticoid receptor (GR)-mediated HPA-axis feedback (despite a normal mineralocorticoid receptor (MR)-mediated tone) and lower tolerance for sound loudness with suppressed cortisol levels. Long-term stress exposure and its deleterious effects therefore constitute an important predisposing factor for, or a significant pathological consequence of, this debilitating hearing disorder.

Abstract Image

Abstract Image

Abstract Image

低剂量地塞米松刺激后耳鸣的皮质醇抑制和听力阈值。
背景:耳鸣是一种常见的、使人衰弱的听力障碍,伴随着严重的情绪和心理痛苦。尽管压力和耳鸣之间的联系已经被广泛认识到,但经验证据很少。我们的目的是测试耳鸣中与压力相关的下丘脑-垂体-肾上腺(HPA)轴的失调,并检查皮质醇操作对耳朵敏感性的影响。方法:21名耳鸣参与者和21名年龄、教育程度和总体健康状况相似但无耳鸣的对照者在非连续三天接受了基础皮质醇评估,并在第一天23:00服用了0.5 mg地塞米松(DEX)。第二天早上每小时测量皮质醇水平。在地塞米松抑制试验前后测量检测和不适听阈。结果:两组的基础皮质醇水平相似,但耳鸣参与者在服用DEX后表现出更强、更持久的皮质醇抑制。抑制与听力损失无关。耳鸣耳朵皮质醇抑制后,不适阈值降低。结论:我们的研究结果表明,耳鸣患者的糖皮质激素敏感性升高,表现为糖皮质激素受体(GR)介导的HPA轴反馈异常强烈(尽管盐皮质激素受体介导的音调正常),以及皮质醇水平受抑时对声音响度的耐受性较低。因此,长期的压力暴露及其有害影响构成了这种使人衰弱的听力障碍的一个重要诱发因素或重要的病理后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Ear, Nose and Throat Disorders
BMC Ear, Nose and Throat Disorders Medicine-Otorhinolaryngology
CiteScore
3.30
自引率
0.00%
发文量
0
期刊介绍: BMC Ear, Nose and Throat Disorders is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of ear, nose and throat disorders, as well as related molecular genetics, pathophysiology, and epidemiology. BMC Ear, Nose and Throat Disorders (ISSN 1472-6815) is indexed/tracked/covered by PubMed, CAS, EMBASE, Scopus and Google Scholar.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信